Endometriosis study: Triptorelin Embonate
Official title Effect GnRH Agonist Administration in Endometriosis Cyst Patients
ClinicalTrials.gov ID: NCT06525155
What this study is testing
What is Triptorelin Embonate?
An investigational injectable medicine being studied for the treatment of endometriosis. It is designed to suppress ovarian hormone production.
Also referred to as Pamorelin.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see whether a 6‑week dosing schedule of triptorelin is as effective as the usual 4‑week schedule for reducing pain and affecting hormone levels in endometriosis patients.
- Who it's for
- Women who have endometriosis cysts and are scheduled for surgery.
- What's involved
- Participants will receive triptorelin injections either twice before surgery (at week 0 and week 6) and once after surgery (week 12) or only once after surgery (week 12). Pain will be measured with a pain scale, and hormone levels will be checked before treatment and before surgery. The condition of the uterus and cysts will be examined during surgery.
- Time commitment
- The study lasts 18 weeks, with visits at baseline, week 6, week 12 (before surgery), and week 18 for pain and hormone assessments, plus the surgery visit.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Female people aged 18 to 40 years.
- The people was diagnosed with endometriosis cysts.
- Willing to participate in research and sign informed consent before all research-related activities begin.
- Regular menstruation (within 25 - 35 day intervals) in the last 3 months before the study was conducted.
You likely can't join if
- The patient used hormonal contraception in the last 3 months prior to the study.
- Using a GnRH agonist within the past 3 months.
- Using the hormone progesterone within the last 3 months
- Pregnancy, breastfeeding females
- History of osteoporosis
- History of blood clotting disorders
See the full eligibility criteria
- Female people aged 18 to 40 years.
- The people was diagnosed with endometriosis cysts.
- Willing to participate in research and sign informed consent before all research-related activities begin.
- Regular menstruation (within 25 - 35 day intervals) in the last 3 months before the study was conducted.
- The patient used hormonal contraception in the last 3 months prior to the study.
- Using a GnRH agonist within the past 3 months.
- Using the hormone progesterone within the last 3 months
- Pregnancy, breastfeeding females
- History of osteoporosis
- History of blood clotting disorders
- History of heart and blood vessel disorders
The study team makes the final eligibility decision.
Where it is enrolling
- Jakarta, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Jakarta, Indonesia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.